Mutant huntingtin protein: a substrate for transglutaminase 1, 2, and 3. (Q40457537)

20 September 2017

title

Mutant huntingtin protein: a substrate for transglutaminase 1, 2, and 3. (English)

1 reference

20 September 2017

5

1 reference

20 September 2017

3

Christopher A Ross

1 reference

20 September 2017

Gina M Zainelli

1

1 reference

20 September 2017

Nichole L Dudek

series ordinal

2

1 reference

20 September 2017

Soo-Youl Kim

series ordinal

4

1 reference

20 September 2017

publication date

1 January 2005

1 reference

Journal of Neuropathology & Experimental Neurology

20 September 2017

published in

1 reference

20 September 2017

volume

64

1 reference

20 September 2017

issue

1

1 reference

20 September 2017

page(s)

58-65

1 reference

Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and pallidoluysian atrophy: correlation between the density of inclusions and IT15 CAG triplet repeat length

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1093/JNEN/64.1.58

Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/JNEN/64.1.58

Neuronal distribution of intranuclear inclusions in Huntington's disease with adult onset.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/JNEN/64.1.58

Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/JNEN/64.1.58

Huntington's disease intranuclear inclusions contain truncated, ubiquitinated huntingtin protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/JNEN/64.1.58

Cellular transglutaminases in neural development

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/JNEN/64.1.58

Pathogenesis of inclusion bodies in (CAG)n/Qn-expansion diseases with special reference to the role of tissue transglutaminase and to selective vulnerability

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/JNEN/64.1.58

Transglutaminase aggregates huntingtin into nonamyloidogenic polymers, and its enzymatic activity increases in Huntington's disease brain nuclei

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/JNEN/64.1.58

Transglutaminase action imitates Huntington's disease: selective polymerization of Huntingtin containing expanded polyglutamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/JNEN/64.1.58

Peptides containing glutamine repeats as substrates for transglutaminase-catalyzed cross-linking: relevance to diseases of the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/JNEN/64.1.58

Transglutaminase cross-links in intranuclear inclusions in Huntington disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/JNEN/64.1.58

GTP-dependent conformational changes associated with the functional switch between Galpha and cross-linking activities in brain-derived tissue transglutaminase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/JNEN/64.1.58

Intron-exon swapping of transglutaminase mRNA and neuronal Tau aggregation in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/JNEN/64.1.58

Injury-induced "switch" from GTP-regulated to novel GTP-independent isoform of tissue transglutaminase in the rat spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/JNEN/64.1.58

Transglutaminase activity, protein, and mRNA expression are increased in progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/JNEN/64.1.58

Prolonged survival and decreased abnormal movements in transgenic model of Huntington disease, with administration of the transglutaminase inhibitor cystamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/JNEN/64.1.58

Formic acid dissolves aggregates of an N-terminal huntingtin fragment containing an expanded polyglutamine tract: applying to quantification of protein components of the aggregates

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/JNEN/64.1.58

Elevated transglutaminase-induced bonds in PHF tau in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/JNEN/64.1.58

Transglutaminase bonds in neurofibrillary tangles and paired helical filament tau early in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/JNEN/64.1.58

Cross-linking of ubiquitin, HSP27, parkin, and alpha-synuclein by gamma-glutamyl-epsilon-lysine bonds in Alzheimer's neurofibrillary tangles

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/JNEN/64.1.58

Differential expression of multiple transglutaminases in human brain. Increased expression and cross-linking by transglutaminases 1 and 2 in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/JNEN/64.1.58

Transglutaminases in disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/JNEN/64.1.58

Brain transglutaminase: in vitro crosslinking of human neurofilament proteins into insoluble polymers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/JNEN/64.1.58

Suppression of aggregate formation and apoptosis by transglutaminase inhibitors in cells expressing truncated DRPLA protein with an expanded polyglutamine stretch.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/JNEN/64.1.58

Comparison of the LDH and MTT assays for quantifying cell death: validity for neuronal apoptosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/JNEN/64.1.58

Calmodulin regulates transglutaminase 2 cross-linking of huntingtin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/JNEN/64.1.58

Tissue transglutaminase-induced aggregation of alpha-synuclein: Implications for Lewy body formation in Parkinson's disease and dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/JNEN/64.1.58

21 January 2018

Identifiers

DOI

10.1093/JNEN/64.1.58

1 reference

20 September 2017

1 reference